Radiomic Models Predict Tumor Microenvironment Using Artificial Intelligence-the Novel Biomarkers in Breast Cancer Immune Microenvironment
- PMID: 38111330
- PMCID: PMC10734346
- DOI: 10.1177/15330338231218227
Radiomic Models Predict Tumor Microenvironment Using Artificial Intelligence-the Novel Biomarkers in Breast Cancer Immune Microenvironment
Abstract
Breast cancer is the most common malignancy in women, and some subtypes are associated with a poor prognosis with a lack of efficacious therapy. Moreover, immunotherapy and the use of other novel antibody‒drug conjugates have been rapidly incorporated into the standard management of advanced breast cancer. To extract more benefit from these therapies, clarifying and monitoring the tumor microenvironment (TME) status is critical, but this is difficult to accomplish based on conventional approaches. Radiomics is a method wherein radiological image features are comprehensively collected and assessed to build connections with disease diagnosis, prognosis, therapy efficacy, the TME, etc In recent years, studies focused on predicting the TME using radiomics have increasingly emerged, most of which demonstrate meaningful results and show better capability than conventional methods in some aspects. Beyond predicting tumor-infiltrating lymphocytes, immunophenotypes, cytokines, infiltrating inflammatory factors, and other stromal components, radiomic models have the potential to provide a completely new approach to deciphering the TME and facilitating tumor management by physicians.
Keywords: biomarker; breast cancer; immunotherapy; radiological images; radiomics; tumor microenvironment.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures



Similar articles
-
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.EBioMedicine. 2021 Jul;69:103460. doi: 10.1016/j.ebiom.2021.103460. Epub 2021 Jul 4. EBioMedicine. 2021. PMID: 34233259 Free PMC article. Clinical Trial.
-
Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.J Transl Med. 2022 Oct 15;20(1):471. doi: 10.1186/s12967-022-03688-x. J Transl Med. 2022. PMID: 36243806 Free PMC article.
-
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.Oncologist. 2022 Jun 8;27(6):e471-e483. doi: 10.1093/oncolo/oyac036. Oncologist. 2022. PMID: 35348765 Free PMC article. Review.
-
Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis.J Transl Med. 2023 Sep 6;21(1):598. doi: 10.1186/s12967-023-04437-4. J Transl Med. 2023. PMID: 37674169 Free PMC article. Review.
-
Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors.Front Immunol. 2023 Jan 5;13:1038089. doi: 10.3389/fimmu.2022.1038089. eCollection 2022. Front Immunol. 2023. PMID: 36660547 Free PMC article.
Cited by
-
Spatial-temporal radiogenomics in predicting neoadjuvant chemotherapy efficacy for breast cancer: a comprehensive review.J Transl Med. 2025 Jun 18;23(1):681. doi: 10.1186/s12967-025-06641-w. J Transl Med. 2025. PMID: 40533825 Free PMC article. Review.
-
Radiomic Fingerprinting of the Peritumoral Edema in Brain Tumors.Cancers (Basel). 2025 Feb 1;17(3):478. doi: 10.3390/cancers17030478. Cancers (Basel). 2025. PMID: 39941846 Free PMC article.
-
Current Architectural and Developmental Approaches in Artificial Intelligence Models for Prostate Cancer Detection and Management: A Technical Report.Cureus. 2025 Apr 5;17(4):e81748. doi: 10.7759/cureus.81748. eCollection 2025 Apr. Cureus. 2025. PMID: 40330342 Free PMC article.
-
Integrating plasma exosomal miRNAs, ultrasound radiomics and tPSA for the diagnosis and prediction of early prostate cancer: a multi-center study.Clin Transl Oncol. 2025 Mar;27(3):1248-1262. doi: 10.1007/s12094-024-03682-3. Epub 2024 Aug 28. Clin Transl Oncol. 2025. PMID: 39196498
-
Artificial Intelligence Advancements in Oncology: A Review of Current Trends and Future Directions.Biomedicines. 2025 Apr 13;13(4):951. doi: 10.3390/biomedicines13040951. Biomedicines. 2025. PMID: 40299653 Free PMC article. Review.
References
-
- Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol. 2006;24(20):3293‐3298. - PubMed
-
- García-Figueiras R, Baleato-González S, Luna A, et al. Assessing immunotherapy with functional and molecular imaging and radiomics. RadioGraphics. 2020;40(7):1987‐2010. - PubMed
-
- Marin Z, Batchelder KA, Toner BC, et al. Mammographic evidence of microenvironment changes in tumorous breasts. Med Phys. 2017;44(4):1324‐1336. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical